Standard InChI: InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34) (Source: PubChem)
IUPAC Name: 5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine (Source: PubChem)
PubChem CID: 68165256 (Source: PubChem)
SMILES String: CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC (Source: PubChem)
Connectivity SMILES string: CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC (Source: PubChem)
Standard InChIKey: AILRADAXUVEEIR-UHFFFAOYSA-N (Source: PubChem)
CAS Registry Number: 1197953-54-0 (Source: PubChem)
ChEBI ID: CHEBI:232810 (Source: PubChem)
ChEMBL ID: CHEMBL3545311 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID501513495 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID501027929 (Source: PubChem)
Wikidata ID: Q27456393 (Source: PubChem)
WHO ATC Classification Drug Code: L01ED04 (Source: ChEMBL)
WHO ATC Classification Drug Name: Brigatinib (Source: ChEMBL)
British National Formulary: Brigatinib (Source: ChEMBL)
Connectivity SMILES string: COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1 (Source: ChEMBL)
European Medicines Agency Name: Brigatinib (Source: ChEMBL)
International Nonproprietary Name: Brigatinib (Source: ChEMBL)
Merck Index Name: Brigatinib (Source: ChEMBL)
Preferred Name: BRIGATINIB (Source: ChEMBL)
Standard InChI: InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34) (Source: ChEMBL)
Standard InChIKey: AILRADAXUVEEIR-UHFFFAOYSA-N (Source: ChEMBL)
US Adopted Name: Brigatinib (Source: ChEMBL)